文献速递糖尿病肥胖与代谢综合征

人工甜味剂与2型糖尿病风险:前瞻性NutriNet-Santé队列研究

Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort.
PubMed 文献 · Diabetes Care · 2023-01-01

该研究基于法国NutriNet-Santé前瞻性队列(2009-2022年)的105,588名参与者,评估人工甜味剂总摄入及阿斯巴甜、安赛蜜-K、三氯蔗糖与2型糖尿病风险的关联。中位随访9.1年期间发生972例2型糖尿病,较高摄入者(高于性别特异性中位数:男性16.4 mg/天、女性18.5 mg/天)相比非摄入者2型糖尿病风险升高(HR 1.69;95%CI 1.45-1.97;P-trend<0.001)。作者认为这些正相关发现强化了人工甜味剂可能并非安全糖替代品的证据。

要点

  • 较高人工甜味剂摄入者(高于性别特异性中位数)相比非摄入者2型糖尿病风险升高:HR 1.69(95%CI 1.45-1.97;P-trend<0.001)。
  • 阿斯巴甜、安赛蜜-K和三氯蔗糖摄入均与2型糖尿病风险呈正相关。
  • 作者指出不能排除反向因果,但已进行多项敏感性分析以限制该偏倚及其他潜在偏倚。

核心结论

  • 人工甜味剂摄入与2型糖尿病风险呈正相关,作者认为这些发现强化了人工甜味剂可能并非安全糖替代品的证据。
  • 作者指出不能排除反向因果,但已进行多项敏感性分析以限制该偏倚及其他潜在偏倚。

研究设计与样本

  • 研究为基于法国NutriNet-Santé网络队列的前瞻性队列分析,纳入105,588名参与者(2009-2022年;平均年龄42.5±14.6岁;79.2%为女性)。
  • 通过重复24小时膳食记录(含工业产品品牌和商品名)结合食品添加剂定性定量组成数据,准确评估所有膳食来源的人工甜味剂摄入量。
  • 采用Cox比例风险模型分析人工甜味剂(总量、阿斯巴甜、安赛蜜-K、三氯蔗糖)与2型糖尿病的关联,并调整潜在混杂因素(包括随访期间体重变化)。

主要发现

  • 中位随访9.1年(946,650人年,972例新发2型糖尿病)期间,较高人工甜味剂摄入者(高于性别特异性中位数:男性16.4 mg/天、女性18.5 mg/天)相比非摄入者2型糖尿病风险升高:HR 1.69(95%CI 1.45-1.97;P-trend<0.001)。
  • 阿斯巴甜摄入与2型糖尿病风险正相关:HR 1.63(95%CI 1.38-1.93;P-trend<0.001)。
  • 安赛蜜-K摄入与2型糖尿病风险正相关:HR 1.70(95%CI 1.42-2.04;P-trend<0.001)。
  • 三氯蔗糖摄入与2型糖尿病风险正相关:HR 1.34(95%CI 1.07-1.69;P-trend=0.013)。

局限性

  • 作者指出不能排除反向因果,但已进行多项敏感性分析以限制该偏倚及其他潜在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the relationships between artificial sweeteners, accounting for all dietary sources (total and by type of artificial sweetener) and risk of type 2 diabetes (T2D), in a large-scale prospective cohort. RESEARCH DESIGN AND METHODS: The analyses included 105,588 participants from the web-based NutriNet-Santé study (France, 2009-2022; mean age 42.5 ± 14.6 years, 79.2% women). Repeated 24-h dietary records, including brands and commercial names of industrial products, merged with qualitative and quantitative food additive composition data, enabled artificial sweetener intakes to be accurately assessed from all dietary sources. Associations between artificial sweeteners (total, aspartame, acesulfame potassium [K], and sucralose) and T2D were investigated using Cox proportional hazard models adjusted for potential confounders, including weight variation during follow-up. RESULTS: During a median follow-up of 9.1 years (946,650 person-years, 972 incident T2D), compared with nonconsumers, higher consumers of artificial sweeteners (i.e., above the sex-specific medians of 16.4 mg/day in men and 18.5 mg/day in women) had higher risks of developing T2D (hazard ratio [HR] 1.69; 95% CI 1.45-1.97; P-trend <0.001). Positive associations were also observed for individual artificial sweeteners: aspartame (HR 1.63 [95% CI 1.38-1.93], P-trend <0.001), acesulfame-K (HR 1.70 [1.42-2.04], P-trend <0.001), and sucralose (HR 1.34 [1.07-1.69], P-trend = 0.013). CONCLUSIONS: Potential for reverse causality cannot be eliminated; however, many sensitivity analyses were computed to limit this and other potential biases. These findings of positive associations between artificial sweetener intakes and increased T2D risk strengthen the evidence that these additives may not be safe sugar alternatives. This study provides important insights in the context of on-going reevaluation of artificial sweeteners by health authorities worldwide.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Debras C, Deschasaux-Tanguy M, Chazelas E, et al. Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort. Diabetes Care. 2023. PMID: 37490630. doi:10.2337/dc23-0206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。